Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy
Papamichael, Konstantinos, Cheifetz, Adam S
Published in The American journal of gastroenterology (01.05.2017)
Published in The American journal of gastroenterology (01.05.2017)
Get full text
Journal Article
Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis
Nanda, Kavinderjit S, Cheifetz, Adam S, Moss, Alan C
Published in The American journal of gastroenterology (01.01.2013)
Published in The American journal of gastroenterology (01.01.2013)
Get full text
Journal Article
Therapeutic drug monitoring in patients on biologics: lessons from gastroenterology
Papamichael, Konstantinos, Cheifetz, Adam S
Published in Current opinion in rheumatology (01.07.2020)
Published in Current opinion in rheumatology (01.07.2020)
Get more information
Journal Article
Review article: emerging drug therapies in inflammatory bowel disease
Grossberg, Laurie B., Papamichael, Konstantinos, Cheifetz, Adam S.
Published in Alimentary pharmacology & therapeutics (01.04.2022)
Published in Alimentary pharmacology & therapeutics (01.04.2022)
Get full text
Journal Article
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease
Cheifetz, Adam S., Abreu, Maria T., Afif, Waqqas, Cross, Raymond K., Dubinsky, Marla C., Loftus, Edward V., Osterman, Mark T., Saroufim, Ariana, Siegel, Corey A., Yarur, Andres J., Melmed, Gil Y., Papamichael, Konstantinos
Published in The American journal of gastroenterology (01.10.2021)
Published in The American journal of gastroenterology (01.10.2021)
Get full text
Journal Article
Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease
Juncadella, Anna, Papamichael, Konstantinos, Vaughn, Byron P., Cheifetz, Adam S.
Published in Digestive diseases and sciences (01.11.2018)
Published in Digestive diseases and sciences (01.11.2018)
Get full text
Journal Article
Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease
Rakowsky, Shana, Cheifetz, Adam S., Papamichael, Konstantinos
Published in Alimentary pharmacology & therapeutics (01.10.2021)
Published in Alimentary pharmacology & therapeutics (01.10.2021)
Get full text
Journal Article
Association Between Serum Infliximab Trough Concentrations During Maintenance Therapy and Biochemical, Endoscopic, and Histologic Remission in Crohn's Disease
Papamichael, Konstantinos, Rakowsky, Shana, Rivera, Claudio, Cheifetz, Adam S, Osterman, Mark T
Published in Inflammatory bowel diseases (15.09.2018)
Published in Inflammatory bowel diseases (15.09.2018)
Get full text
Journal Article
Improved Long-Term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab
Papamichael, Konstantinos, Chachu, Karen A, Vajravelu, Ravy, Vaughn, Byron P, Ni, Josephine, Osterman, Mark T, Cheifetz, Adam S
Published in Clinical gastroenterology and hepatology (01.10.2017)
Published in Clinical gastroenterology and hepatology (01.10.2017)
Get full text
Journal Article
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn’s Disease
Roblin, Xavier, Moschetti, Estelle, Barrau, Mathilde, Cheifetz, Adam S., Papamichael, Konstantinos, Paul, Stephane
Published in Clinical gastroenterology and hepatology (01.11.2024)
Published in Clinical gastroenterology and hepatology (01.11.2024)
Get full text
Journal Article